Logo image
Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin
Journal article   Open access   Peer reviewed

Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin

Christine L Oltman, Eric P Davidson, Lawrence J Coppey, Travis L Kleinschmidt, Donald D Lund and Mark A Yorek
Obesity (Silver Spring, Md.), Vol.16(1), pp.82-89
01/2008
DOI: 10.1038/oby.2007.19
PMID: 18223617
url
https://doi.org/10.1038/oby.2007.19View
Published (Version of record) Open Access

Abstract

Obese Zucker rats, animal model for the metabolic syndrome, develop a diabetes-like neuropathy that is independent of hyperglycemia. The purpose of this study was to determine whether drugs used to treat cardiovascular dysfunction in metabolic syndrome also protect nerve function. Obese Zucker rats at 20 weeks of age were treated for 12 weeks with enalapril or rosuvastatin. Lean rats were used as controls. Vasodilation in epineurial arterioles was measured by videomicroscopy. Endoneurial blood flow (EBF) was measured by hydrogen clearance and nerve conduction velocity was measured following electrical stimulation of motor or sensory nerves. Enalapril treatment decreased serum angiotensin-converting enzyme (ACE) activity and both drugs reduced serum cholesterol levels. In obese Zucker rats at 32 weeks of age superoxide levels were elevated in the aortas and epineurial arterioles, which were reduced by treatment with either drug. Nitrotyrosine levels were increased in epineurial arterioles and reduced with enalapril treatment. EBF was decreased and corrected by treatment with either drug. Motor nerve conduction velocity was decreased and significantly improved with enalapril treatment. Obese Zucker rats were hypoalgesic in response to a thermal stimulus and this was significantly improved with either treatment. Treatment with either enalapril or rosuvastatin significantly reversed the decrease in acetylcholine-mediated vascular relaxation of epineurial arterioles in obese Zucker rats. Even though obese Zucker rats have normal glycemia vascular and neural dysfunctions develop with age and can be improved by treatment with either enalapril or rosuvastatin.
Arterioles - physiology Sciatic Nerve - physiology Nociceptors - physiology Male Peripheral Nerves - drug effects Sciatic Nerve - blood supply Tyrosine - analogs & derivatives Fluorobenzenes - pharmacology Cardiovascular System - physiopathology Metabolic Syndrome - physiopathology Superoxides - metabolism Angiotensin-Converting Enzyme Inhibitors - pharmacology Neural Conduction - drug effects Motor Neurons - drug effects Disease Models, Animal Neurons, Afferent - drug effects Motor Neurons - physiology Vasodilator Agents - pharmacology Acetylcholine - pharmacology Rats Rosuvastatin Calcium Neural Conduction - physiology Obesity - physiopathology Cardiovascular System - drug effects Pyrimidines - pharmacology Sulfonamides - pharmacology Arterioles - drug effects Neurons, Afferent - physiology Peripheral Nerves - physiopathology Rats, Zucker Tyrosine - metabolism Animals Enalapril - pharmacology Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology Nociceptors - drug effects

Details

Metrics

Logo image